Comments
Loading...

Silence Therapeutics

SLNNASDAQ
Logo brought to you by Benzinga Data
$18.26
00.00%
At close: Sep 18, 4:00 PM EDT
$18.26
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$75.00
Lowest Price Target1
$18.00
Consensus Price Target1
$52.80

Silence Therapeutics (NASDAQ:SLN) Stock, Analyst Ratings, Price Targets, Forecasts

Silence Therapeutics PLC has a consensus price target of $52.8 based on the ratings of 5 analysts. The high is $75 issued by HC Wainwright & Co. on August 30, 2024. The low is $18 issued by Morgan Stanley on December 9, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Chardan Capital, and Morgan Stanley on August 30, 2024, August 16, 2024, and June 28, 2024, respectively. With an average price target of $59.67 between HC Wainwright & Co., Chardan Capital, and Morgan Stanley, there's an implied 226.76% upside for Silence Therapeutics PLC from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
0
0
0
0
May
1
Jun
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Chardan Capital
Morgan Stanley
BMO Capital
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Silence Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Silence Therapeutics (SLN) stock?

A

The latest price target for Silence Therapeutics (NASDAQ:SLN) was reported by HC Wainwright & Co. on August 30, 2024. The analyst firm set a price target for $75.00 expecting SLN to rise to within 12 months (a possible 310.73% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Silence Therapeutics (SLN)?

A

The latest analyst rating for Silence Therapeutics (NASDAQ:SLN) was provided by HC Wainwright & Co., and Silence Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Silence Therapeutics (SLN)?

A

There is no last upgrade for Silence Therapeutics

Q

When was the last downgrade for Silence Therapeutics (SLN)?

A

There is no last downgrade for Silence Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Silence Therapeutics (SLN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silence Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silence Therapeutics was filed on August 30, 2024 so you should expect the next rating to be made available sometime around August 30, 2025.

Q

Is the Analyst Rating Silence Therapeutics (SLN) correct?

A

While ratings are subjective and will change, the latest Silence Therapeutics (SLN) rating was a reiterated with a price target of $75.00 to $75.00. The current price Silence Therapeutics (SLN) is trading at is $18.26, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch